veyosffm | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/veyosffm_hasAnnotation_C0242708>
?:creator	<https://research.tib.eu/covid-19/entity/Lohse%2C_Anne%3B_Bossert%2C_Marie%3B_Bozgan%2C_Ana-Maria%3B_Charpentier%2C_Aline%3B_Guillochon%2C_Cerise%3B_Bourgoin%2C_Charlotte%3B_Balblanc%2C_Jean-Charles%3B_Conrozier%2C_Thierry>
?:externalLink	<https://www.ncbi.nlm.nih.gov/pubmed/33253100/>
?:journal	Clinical_and_experimental_rheumatology
?:license	unk
?:pmid	<https://research.tib.eu/covid-19/entity/33253100.0>
?:pmid	33253100.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/veyosffm_HAS_C0242708_TREATS_C0035436>
?:source	Medline
?:title	Frequency and severity of COVID-19 in patients treated with biological disease-modifying anti-rheumatic drugs for inflammatory rheumatic disease: a cross-sectional study.
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-22

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/veyosffm>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/veyosffm>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all